Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Ligand Pharm (LGND)

Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ligand: Q1 Earnings Snapshot AP - Tue May 7, 3:45PM CDT

Ligand: Q1 Earnings Snapshot

LGND : 87.28 (+1.35%)
Ligand: Q4 Earnings Snapshot AP - Tue Feb 27, 6:33AM CST

Ligand: Q4 Earnings Snapshot

LGND : 87.28 (+1.35%)
Ligand: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Ligand: Q3 Earnings Snapshot

LGND : 87.28 (+1.35%)
Ligand: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Ligand: Q2 Earnings Snapshot

LGND : 87.28 (+1.35%)
Exelixis (EXEL) Q1 Earnings Miss, Revenues Increase Y/Y Zacks - Wed May 10, 2023

Exelixis (EXEL) misses first quarter 2023 earnings and sales estimates, but product sales increase year over year.

BMY : 44.94 (+0.45%)
EXEL : 21.37 (-1.79%)
LGND : 87.28 (+1.35%)
SPRO : 1.6400 (-2.96%)
bluebird (BLUE) Posts Q1 Earnings, Focuses on Zynteglo, Skysona Zacks - Wed May 10, 2023

bluebird bio (BLUE) delivers earnings of 21 cents per share in the first quarter, due to a one-time gain. Revenues increase year over year.

LGND : 87.28 (+1.35%)
PCRX : 29.42 (-1.47%)
BLUE : 1.0600 (-5.36%)
SPRO : 1.6400 (-2.96%)
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View Zacks - Wed May 10, 2023

Novavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However, shares rise on the back of encouraging 2023 guidance and cost-reduction initiatives.

NVAX : 8.88 (+98.66%)
LGND : 87.28 (+1.35%)
ALLO : 2.76 (-3.50%)
ATHA : 2.12 (-4.50%)
Denali (DNLI) Q1 Earnings Miss Estimates, Pipeline in Focus Zacks - Tue May 9, 2023

Denali (DNLI) delivers a wider Q1 loss while collaboration revenues surpass estimates.

SNY : 49.28 (+1.21%)
BIIB : 221.50 (-0.56%)
LGND : 87.28 (+1.35%)
DNLI : 18.31 (-1.93%)
Viatris (VTRS) Q1 Earnings Beat, Revenues Miss Estimates Zacks - Mon May 8, 2023

Viatris (VTRS) beats on Q1 earnings but misses sales. The company is now looking to reshape its business after selling its biosimilars portfolio.

LGND : 87.28 (+1.35%)
PCRX : 29.42 (-1.47%)
SPRO : 1.6400 (-2.96%)
VTRS : 11.16 (-0.53%)
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings Zacks - Mon May 8, 2023

Ligand Pharmaceuticals (LGND) announces better-than-expected results in first-quarter 2023. Management raises 2023 financial outlook.

LGND : 87.28 (+1.35%)
VKTX : 73.64 (-8.18%)
TVTX : 6.30 (-4.55%)
OABI : 4.68 (+2.41%)

Barchart Exclusives

2 Silver Mining Stocks to Buy While They're Cheap Barchart - 48 minutes ago
Here are two low-priced silver mining stocks that analysts expect to rally from here. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot